XML 118 R32.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SHARE CAPITAL (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Equity [Abstract] |
SCHEDULE OF GRANT DATE FAIR VALUE OF PREFERRED INVESTMENT OPTIONS ISSUED TO INVESTORS | The grant date fair values of preferred investment options issued to Wainwright and preferred investment options issued to investors that were modified in the years ended December 31, 2023 and 2022 were estimated using the Black-Scholes valuation model with the following: SCHEDULE OF GRANT DATE FAIR VALUE OF PREFERRED INVESTMENT OPTIONS ISSUED TO INVESTORS
|  | For the Years Ended December 31, |
|  | 2023 |  |  | 2022 |
Expected volatility |  |  | 101.31%-122.39% |  |  |  | 87.96 | %
Risk-free interest |  |  | 3.85%- 4.93% |  |  |  | 4.25 | %
Dividend yield |  |  | -% |  |  |  | -% |
Expected terms (years) |  |  | 1.42-5 |  |  |  | 4.99 |
SUMMARY OF STOCK OPTION ACTIVITY | SUMMARY OF STOCK OPTION ACTIVITY
|  | For the Year Ended December 31, 2023 |
|  | Number of stock options |  |  | Weighted average exercise price |
Outstanding as of December 31, 2022 |  |  | 1,507,137 |  |  | $ | 7.31 |
Granted |  |  | 711,308 |  |  |  | 1.75 |
Forfeitures |  |  | (123,083 | ) |  |  | 5.78 |
Outstanding as of December 31, 2023 |  |  | 2,095,362 |  |  | $ | 5.51 |
Vested as of December 31, 2023 |  |  | 1,176,118 |  |  | $ | 7.74 |
|  | For the Year Ended December 31, 2022 |
|  | Number of stock options |  |  | Weighted average exercise price |
Outstanding as of December 31, 2021 |  |  | 997,148 |  |  | $ | 8.48 |
Granted |  |  | 530,822 |  |  |  | 5.14 |
Forfeitures |  |  | (20,833 | ) |  |  | 8.16 |
Outstanding as of December 31, 2022 |  |  | 1,507,137 |  |  | $ | 7.31 |
Vested as of December 31, 2022 |  |  | 899,609 |  |  | $ | 8.52 |
SCHEDULE OF STOCK OPTIONS OUTSTANDING | The stock options outstanding as of December 31, 2023 and December 31, 2022, summarized by exercise prices, are as follows: SCHEDULE OF STOCK OPTIONS OUTSTANDING
Exercise price $ |  | Stock options outstanding as of December 31, 2023 |  |  | Stock options outstanding as of December 31, 2022 |  |  | Weighted average remaining contractual life - years as of December 31, 2023 |  |  | Weighted average remaining contractual life - years as of December 31, 2022 |  |  | Stock options exercisable as of December 31, 2023 |  |  | Stock options exercisable as of December 31, 2022 |
0.00-0.01 |  |  | 61,577 |  |  |  | 61,577 |  |  |  | 2.3 |  |  |  | 3.3 |  |  |  | 61,577 |  |  |  | 61,577 |
1.00-3.73 |  |  | 860,808 |  |  |  | 211,000 |  |  |  | 9.6 |  |  |  | 10 |  |  |  | 95,925 |  |  |  | - |
4.2-7.26 |  |  | 639,232 |  |  |  | 687,482 |  |  |  | 6.3 |  |  |  | 8.0 |  |  |  | 484,871 |  |  |  | 315,807 |
8.16-9.64 |  |  | 380,872 |  |  |  | 380,872 |  |  |  | 6.6 |  |  |  | 7.6 |  |  |  | 380,872 |  |  |  | 356,019 |
15.3-15.75 |  |  | 152,873 |  |  |  | 166,206 |  |  |  | 3.7 |  |  |  | 4.8 |  |  |  | 152,873 |  |  |  | 166,206 |
|  |  | 2,095,362 |  |  |  | 1,507,137 |  |  |  |  |  |  |  |  |  |  |  | 1,176,118 |  |  |  | 899,609 |
SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS | The grant date fair values of employee stock options granted in the years ended December 31, 2023 and 2022 were estimated using the Black-Scholes valuation model with the following: SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS
|  | For the Years Ended December 31, |
|  | 2023 |  |  | 2022 |
Expected volatility |  |  | 86.5%-98.2% |  |  |  | 111.2%-161.7% |
Risk-free interest |  |  | 3.3%- 4.7% |  |  |  | 1.7%- 3.7% |
Dividend yield |  |  | -% |  |  |  | -% |
Expected terms (years) |  |  | 5.8 |  |  |  | 6.2 |
SCHEDULE OF WARRANTS OUTSTANDING | The remaining outstanding warrants and terms as of December 31, 2023 and 2022 are as follows: SCHEDULE OF WARRANTS OUTSTANDING
Issuance date |  | Outstanding and exercisable as of December 31, 2023 |  |  | Outstanding and exercisable as of December 31, 2022 |  |  | Exercise Price |  |  | Exercisable Through
Series A (2013) |  |  | - |  |  |  | 183 |  |  | $ | 2,754.00 |  |  | April 9, 2023
Warrant to underwriters December 2019 |  |  | - |  |  |  | 45,643 |  |  | $ | 13.13 |  |  | June 25, 2023
Warrant to underwriters December 2019 |  |  | - |  |  |  | 47,619 |  |  | $ | 13.13 |  |  | June 27, 2023
Warrant to underwriters December 2019 |  |  | - |  |  |  | 45,045 |  |  | $ | 13.88 |  |  | June 30, 2023
Series A October 2022 |  |  | 1,022,495 |  |  |  | 1,022,495 |  |  | $ | 2.20 |  |  | October 25, 2027
Series B October 2022 |  |  | - |  |  |  | 1,022,495 |  |  | $ | 2.20 |  |  | October 25, 2027
Prefunded warrants October 2022 |  |  | - |  |  |  | 240,000 |  |  | $ | (* | ) |  | No limit
Warrant to underwriters October 2022 |  |  | 51,125 |  |  |  | 51,125 |  |  | $ | 6.11 |  |  | October 21, 2027
Warrant to underwriters May 2023 |  |  | 32,778 |  |  |  | - |  |  | $ | 2.75 |  |  | November 23, 2026
Warrant to underwriters May 2023 |  |  | 60,476 |  |  |  | - |  |  | $ | 2.75 |  |  | November 24, 2026
Warrant to underwriters June 2023 |  |  | 35,088 |  |  |  | - |  |  | $ | 2.67 |  |  | June 2, 2028
Warrant series C June 2023 |  |  | 350,878 |  |  |  | - |  |  | $ | 2.08 |  |  | December 6, 2028
Warrant to underwriters June 2023 |  |  | 31,231 |  |  |  | - |  |  | $ | 4.06 |  |  | June 28, 2028
Warrant series D June 2023 |  |  | 312,309 |  |  |  | - |  |  | $ | 3.19 |  |  | December 28, 2028
(*) |  | Less than $0.01.

X
- Definition Schedule of Grant Date Fair Value of Preferred Investment Options Issued to Investors [Table Text Block] + References No definition available. + Details
Name: | MBOT_ScheduleOfGrantDateFairValueOfPreferredInvestmentOptionsIssuedToInvestorsTableTextBlock
Namespace Prefix: | MBOT_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration